secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2026-06-25T11:10:14+00:00
Accession:  0001628280-26-045350
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics appoints Carolyn Starrett, former Flatiron Health CEO, to board
---------------------------------------------------------------------------

- Board expanded from 9 to 10 directors; Starrett fills new seat effective June 23, 2026.
- Starrett brings 25+ years experience in data/tech, AI, and cancer care; was CEO of Flatiron Health from 2021-2025.
- She will serve until 2027 annual meeting; compensation per standard director program.
- Chair Lynn Tetrault cites Starrett's expertise in real-world data and analytics for cancer care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026045350/0001628280-26-045350-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026045350/neo-20260623.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-045350

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer